Average Co-Inventor Count = 4.21
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurosearch A/s (107 from 206 patents)
2. Aniona Aps (3 from 5 patents)
3. Danpet Ab (3 from 3 patents)
4. Ataxion, Inc. (2 from 4 patents)
5. Abbott Laboratories Corporation (1 from 4,179 patents)
115 patents:
1. 9340544 - Purinyl derivatives and their use as potassium channel modulators
2. 9133184 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
3. 8986654 - Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
4. 8946412 - Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
5. 8778928 - Indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use
6. 8697721 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
7. 8633218 - 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
8. 8618099 - Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators
9. 8415358 - Pyrazine derivatives and their use as potassium channel modulators
10. 8410271 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11. 8372832 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
12. 8362024 - Purinyl derivatives and their use as potassium channel modulators
13. 8343960 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
14. 8268838 - Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators
15. 8263617 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors